Fig. 1From: Pancreatic enzyme replacement therapy in subjects with exocrine pancreatic insufficiency and diabetes mellitus: a real-life, case–control studyEvolution of relevant hypoglycemia and of gastro-intestinal disorders over the study period. Black: PERT group White: Control group. a Evolution of relevant hypoglycemia in subjects treated with PERT and in control subjects, before and after T0. Relevant hypoglycemia: at least 4 documented symptomatic hypoglycemia events per week and/or at least one episode of severe hypoglycemia within the last 2 years before T0. b Evolution of gastro-intestinal disorders before and after T0 in subjects treated with PERT and in control subjectsBack to article page